Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × FED × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

OTHER 124 INDUSTRY 28 NIH 12 NETWORK 8 OTHER_GOV 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Neoplasms 1 Neoplasm Metastasis 1 Head and Neck Neoplasms 1 Carcinoma, Squamous Cell 1

Interventions

Capecitabine 2 leucoselect phytosome 1 gallium 68 PSMA-11 1 Oxaliplatin 1 Midazolam 1 Ketamine 1 Injections 1 Immunoglobulins 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00557206 2013-11-05

Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer

Minneapolis Veterans Affairs Medical Center

Phase 2 Terminated

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡